BUREAU-VERITAS
20.3.2024 10:09:34 CET | Business Wire | Press release
Today, Bureau Veritas hosts its Capital Markets Day during which the Group will present its 2028 strategy and financial ambitions:
- New customer-centric vision, to be the preferred partner for customers’ excellence and sustainability
-
New strategy LEAP I 28 to deliver a step change in growth and performance, built around three pillars: Portfolio, Performance and People, with sustainability at its core:
- Active Portfolio management strategy designed to enhance leadership positions through organic growth, accelerated M&A and portfolio high-grading
- Performance programs identifying meaningful efficiency and productivity benefits from operational leverage, functional scalability and innovation
- An evolved People model, leveraging the Group’s deep-rooted knowledge and expertise to train and develop strategic competencies needed for future growth
- Staying true to its purpose of “Shaping a world of trust by ensuring responsible progress”, Bureau Veritas will be fully engaged to deliver on its CSR commitments
- Ambition 2028: high single-digit total revenue growth1 (with mid-to-high single-digit organic), consistent adjusted operating margin improvement2, double-digit shareholder returns based on EPS CAGR1 and dividend yield, and strong cash conversion2 (above 90%)
- In support of its strategy, and reflecting its financial health, Bureau Veritas intends to acquire its own shares for up to 200 million euro in 2024
Hinda Gharbi, Chief Executive Officer, commented:
“For nearly two centuries, Bureau Veritas has brokered trust between business and society. Building on our long-standing reputation for technical expertise, high quality and integrity, we are uniquely positioned to leverage our global reach and broad capabilities. Our vision is to be the preferred partner for our clients’ excellence and sustainability, enabling our customers to navigate technological and societal changes to transform and perform sustainably.
Our new strategy, LEAP I 28, is a new chapter in our history as we aim to achieve a step change in our leadership and performance, both in terms of growth and shareholder returns.
By actively managing our Portfolio, we aim to be the leader in the markets we serve where we already occupy a top three leadership position, invest to build new growth strongholds in strategic markets and optimize value and impact from the remainder of the portfolio. Our new Performance-centric execution model will enhance our customer value proposition through technology and scalability and will enable opex investments to fund our growth ambition and to drive margin improvement. Our People model will evolve to ensure we attract and develop the strategic competencies needed to enter new markets and sustain higher growth.
We are targeting mid-to-high single digit organic revenue growth, consistent adjusted operating margin improvement and double-digit shareholder returns based on EPS CAGR and dividend yield.
I would like to warmly thank all our colleagues around the world for their dedication and commitment to delivering on our new ambitions. We also thank our shareholders for their continued support.
I’m proud to lead this great company towards its bicentenary with a renewed sense of purpose, energy and ambition, knowing that its best is yet to come.”
A UNIFYING VISION
Bureau Veritas’ unifying vision is to be the preferred partner for customers’ excellence and sustainability. This vision translates into an ambitious, customer-centric strategy, leveraging five secular trends: Sustainability, Energy Transition, Connectivity & Digitalization, Supply Chain Reconfiguration and Urbanization.
LEAP I 28
This new vision translates into a new strategy based on three pillars: Portfolio, Performance and People.
- Portfolio: Pursue undisputed market leadership
Bureau Veritas will actively manage its Portfolio to attain market leadership positions on prioritized and focused businesses.
To this end, the Group will implement a three-fold approach:
- Expand leadership in existing strongholds with established leadership positions, through a combination of rapid organic scaling and inorganic expansion.
- Accelerate growth in selected markets to create new long-term strongholds, investing early in fast growing strategic sectors (sustainability, energy transition and cyber for instance), where the Group has a clear path to market leadership.
- Optimize value and impact from the remainder of the portfolio in a granular and consistent way. Businesses that do not meet stringent financial performance hurdles will be candidates for performance improvement or portfolio high grading.
Portfolio ambition: Existing and new strongholds account for c.55% of 2023 Group revenue and will deliver 80% of incremental organic revenue over 2024-2028. In doing so, the Group expects to reach a top three position in 90% of its portfolio by the end of 2028 (versus 75% in 2023).
Acquisitions play a key role in Bureau Veritas’ strategy. Firmly aligned with its “expand leadership and new strongholds” portfolio strategic directions, the Group is ready to accelerate its M&A ambition. While carrying on its bolt-on strategy, the Group will remain open and attentive to mid-size opportunities (revenue above 100 million euro), in a very disciplined way, consistent with its criteria of strategic fit, price, profitability and value creation.
- Performance: a technology-augmented and modernized execution
The Group will accelerate performance through programs designed to deliver meaningful efficiency and productivity benefits. The objective is to entrench higher granularity in the measurement and management of the day-to-day business. It expects to also elevate customer experience, and service quality versus competitors, and will modernize and scale select operational and functional processes to extract operational efficiencies.
The two programs are Operational Leverage & Functional Scalability and Innovation.
1/ Operational Leverage & Functional Scalability. The Group is enhancing its delivery models, to better serve its customers and ultimately to reduce its cost to serve. Three key areas of focus have been identified to extract operational leverage: i) improving performance management and measurement; ii) modernizing operational and functional processes; iii) developing tech augmented service models.
2/ Innovation. Innovation and technology are the backbone of the Group’s strategy through a three-layered approach. The Group has invested in scalable enterprise systems, mostly cloud-based, to strengthen its global operations across human resources, finance, and sales. Bureau Veritas will also constantly capture data through modernized operations systems, enabling its people in the field and in labs to deliver superior customer service. The third layer enables the Group to innovate with technologies including machine learning and Artificial Intelligence (AI) to address customer needs and create new revenue streams.
Performance Ambition: The Group expects to accelerate growth through additional capacity from enhanced productivity, with the ambition to deliver up to 100 bps of operational leverage and up to 80 bps of functional scalability within the 5-year period. Around half of these performance programs’ savings are to be reinvested.
- People: Evolve Bureau Veritas’ People model
Bureau Veritas is a technical knowledge company with over two thirds of its 83,000 employees possessing specific technical expertise: technicians, engineers, scientists, and other specialists. It excels in attracting and developing capable talents from all around the world. As a service company, Bureau Veritas’ people skills and knowledge are critical to its market differentiation and business success.
Recognizing the new dynamics around people and skills, Bureau Veritas will evolve its people model, leveraging its deep-rooted knowledge and expertise to train and develop in-house strategic competencies needed for future growth, enhancing its competitive advantage.
The Group’s competitive advantage and ability to outpace competition will come from:
1/ “New economy” and strategic skills, around sustainability, energy transition and digital, by developing a new and systematic approach to the way employees’ skills are developed.
2/ “Tech Augmented ways of working”: with the increasing role of technology, Bureau Veritas will develop new tech-augmented service models that require new skills and competencies. These enhanced service models will free experts to focus on adding value, improving productivity, and enhancing customer service quality.
SUSTAINABILITY AT BUREAU VERITAS’ CORE
SUPPORTING CUSTOMERS’ SUSTAINABILITY JOURNEY
As customers’ organizations transform into more sustainable enterprises, the demand for associated services is only increasing. These include a range of activities: corporate strategy, operational transformation advisory, product stewardship and supply-chain reassurance, as well as non-financial reporting.
Bureau Veritas’ mission is to support its customers in their transition journey to a new, sustainable state, through the development of novel solutions, and an active network of experts to support their transformation.
Capitalizing on its technical expertise, field DNA, global reach and independent third-party role, Bureau Veritas’ ambition is to actively support its customers’ sustainability journey from transition to transformation. The Group will leverage its differentiating attributes to build leadership positions in two complementary segments of the market:
-
Transition services: supporting clients’ move to more sustainable business models, through two types of activity:
- ESG transformation services, i.e. supporting the implementation and monitoring of plans,
- Compliance and reporting assistance services, supporting clients’ efforts to comply with and communicate on regulatory and voluntary disclosures;
- Green object services, supporting the build and maintenance of green assets, green products, and green commodities – e.g. renewables, new mobility, green fuels, etc.
Sustainability ambition: The more narrowly defined subset of sustainability services – both transition services and green objects combined, represents circa 5% of 2023 Group revenue and is targeted to grow to 15% of Group revenue by 2028.
2028 CSR AMBITIONS
Staying true to its purpose of “Shaping a world of trust by ensuring responsible progress”, Bureau Veritas must be exemplary in its own sustainability journey.
The Group’s CSR strategy addresses the three dimensions of environment, workplace, and business practices, to drive a positive transformation of Group activities and actions. This is delivered through the engagement of its 83,000 dedicated employees to shape a better environment, to shape a better workplace and to shape better practices. Bureau Veritas will be fully engaged to deliver on its CSR commitment. The Group will also accelerate its efforts built around six priorities: climate, circularity & biodiversity, health & safety, human capital, diversity, and ethics.
The Group is committed to the achievement of five key performance indicators through 2028:
|
UNITED NATIONS’ SDGS |
2023 |
2028 TARGET |
||
ENVIRONMENT / NATURAL CAPITAL |
|
|
|||
CO2 emissions (scope 1 & 2, 1,000 tons) |
#13 |
149 |
107 |
||
SOCIAL & HUMAN CAPITAL |
|
|
|
||
Total Accident Rate (TAR)3 |
#3 |
0.25 |
0.23 |
||
Proportion of women in leadership positions4 |
#5 |
29% |
36% |
||
Number of training hours per employee (per year) |
#8 |
36.1 |
40.0 |
||
GOVERNANCE |
|
|
|||
Proportion of employees trained to the Code of Ethics |
#16 |
97% |
99% |
2028 FINANCIAL AMBITION
Bureau Veritas is now a more resilient business and capable of a step change in growth and profitability. The new mid-term financial targets reflect this ambition:
2024-2028 |
|
GROWTH CAGR |
High-single digit total revenue growth5 |
With: |
Organic: mid-to-high single digit |
And: |
M&A acceleration and portfolio high-grading |
MARGIN |
Consistent adjusted operating margin improvement5 |
EPS CAGR5 + DIVIDEND YIELD |
Double digit returns |
CASH |
Strong cash conversion6: above 90% |
CAPITAL ALLOCATION - AN ACCELERATED EXTERNAL GROWTH POLICY
Over the period 2024-2028, the use of Free Cash Flow generated from our operations will be balanced between Capital Expenditure (Capex), Mergers & Acquisitions (M&A) and shareholder returns (Dividend):
ASSUMPTIONS |
|
CAPEX |
Around 2.5-3.0% of Group revenue |
M&A |
M&A acceleration |
DIVIDEND |
Pay-out of 65% of Adjusted Net Profit |
LEVERAGE |
Between 1.0x-2.0x by 2028 |
In support of its strategy, and reflecting its financial health, Bureau Veritas intends to acquire its own shares for up to 200 million euro in 2024, within the share buyback program approved by the shareholders meeting. This would be funded through available resources.
CONNECTING TO CAPITAL MARKETS DAY
- Schedule (Paris Time): Wednesday March 20, 2024 – 9:00am CET to 13:00pm CET
- The presentation slides will be available at: https://group.bureauveritas.com/capital-markets-day-2024
- Please register and connect to https://investorday-bureauveritas.com/register to access the live event.
FINANCIAL CALENDAR
- Q1 2024 revenue: April 25, 2024
- Shareholders’ Meeting: June 20, 2024
- Half Year 2024 Results: July 26, 2024
- Q3 2024 revenue: October 23, 2024
About Bureau Veritas
Bureau Veritas is a world leader in inspection, certification, and laboratory testing services with a powerful purpose: to shape a world of trust by ensuring responsible progress.
With a vision to be the preferred partner for customers’ excellence and sustainability, the company innovates to help them navigate change.
Created in 1828, Bureau Veritas’ 83,000 employees deliver services in 140 countries. The company’s technical experts support customers to address challenges in quality, health and safety, environmental protection, and sustainability.
Bureau Veritas is listed on Euronext Paris and belongs to the CAC 40 ESG, CAC Next 20, SBF 120 indices and is part of the CAC SBT 1.5° index. Compartment A, ISIN code FR 0006174348, stock symbol: BVI.
For more information, visit www.bureauveritas.com, and follow us on Twitter (@bureauveritas) and LinkedIn.
Our information is certified with blockchain technology.
Check that this press release is genuine at www.wiztrust.com.
This press release (including the appendices) contains forward-looking statements, which are based on current plans and forecasts of Bureau Veritas’ management. Such forward-looking statements are by their nature subject to a number of important risk and uncertainty factors such as those described in the Universal Registration Document (“Document d’enregistrement universel”) filed by Bureau Veritas with the French Financial Markets Authority (“AMF”) that could cause actual results to differ from the plans, objectives and expectations expressed in such forward-looking statements. These forward-looking statements speak only as of the date on which they are made, and Bureau Veritas undertakes no obligation to update or revise any of them, whether as a result of new information, future events or otherwise, according to applicable regulations.
1 At constant currency
2 (Net cash generated from operating activities – lease payments + corporate tax)/adjusted operating profit
3 TAR: Total Accident Rate (number of accidents with and without lost time x 200,000/number of hours worked).
4 Proportion of women from the Executive Committee to Band III (internal grade corresponding to a management or executive management position) in the Group (number of women on a full-time equivalent basis in a leadership position/total number of full-time equivalents in leadership positions).
5 At constant currency.
6 (Net cash generated from operating activities – lease payments + corporate tax)/adjusted operating profit.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240320033795/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
